AVBP
ArriVent BioPharma, Inc.
+0.51 (+1.84%)28.16USD69.3K成交股數1.4B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-16下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 42.3M | 37.6M | 32.2M | 32.2M | 27.7M | 61.3M | 20.1M | 21.8M | 17.0M | 20.0M | 14.3M | 20.4M |
| 銷售管理費用 | 10.4M | 8.5M | 6.6M | 6.1M | 5.9M | 5.5M | 4.1M | 3.9M | 3.7M | 3.1M | 2.4M | 2.2M |
| 營業利益 | −52.7M+57% | −46.1M-31% | −38.8M+60% | −38.3M+49% | −33.6M+63% | −66.8M+189% | −24.2M+45% | −25.7M+14% | −20.7M | −23.1M | −16.7M | −22.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −49.9M+59% | −43.3M-33% | −35.5M+73% | −35.0M+60% | −31.4M+80% | −64.4M+204% | −20.6M+43% | −21.9M+1% | −17.4M | −21.2M | −14.4M | −21.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -1.05+17% | -0.96-49% | -0.69+13% | -0.83+28% | -0.90+29% | -1.90-71% | -0.61-89% | -0.65-94% | -0.70 | -6.62 | -5.52 | -10.79 |
| 稀釋股數 | 47.6M | 45.1M | 38.5M | 41.9M | 35.0M | 33.9M | 33.6M | 33.5M | 25.0M | 2.1M | 2.6M | 2.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 155M | 62.1M | 45.5M | 113M | 113M | 49.9M | 283M | 299M | 317M | 150M | 141M | 158M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 395M | 349M | 333M | 327M | 270M | 215M | 293M | 309M | 328M | 163M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 27.9M | 25.3M | 25.9M | 21.6M | 19.6M | 13.0M | 15.2M | 12.2M | 10.1M | 11.8M | – | – |
| 股東權益 | 367M | 324M | 307M | 305M | 250M | 203M | 277M | 297M | 318M | −153M | −133M | −118M |
| 負債比 | 7.1% | 7.2% | 7.8% | 6.6% | 7.3% | 6.0% | 5.2% | 3.9% | 3.1% | 7.2% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −41.9M-38% | – | – | – | −68.0M | – | – | −18.6M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | −559K | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −166M | –% | -4.32 | – |
| FY2024 | – | – | −80.5M | –% | -2.56 | – |
| FY2023 | – | – | −69.3M | –% | -32.38 | – |